About
Lumabs develops a next-generation bioluminescence-based immunoassay platform called RAPPID, which enables rapid, sensitive, and quantitative antibody or antigen detection directly in biological samples without complex sample preparation.
Explore Lumabs's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.